Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Axelson
The HDAC Inhibitor LBH589 Enhances the Antimyeloma Effects of the IGF-1RTK Inhibitor Picropodophyllin
Clinical Cancer Research
Cancer Research
Oncology
Lipoprotein Metabolism in Patients With Anorexia Nervosa: A Case–control Study Investigating the Mechanisms Leading to Hypercholesterolaemia
British Journal of Nutrition
Medicine
Nutrition
Dietetics
Related publications
The HDAC Inhibitor LBH589 (Panobinostat) Is an Inhibitory Modulator of Aromatase Gene Expression
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-Pd-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment
Journal of Cancer
Oncology
Host Histone Acetylation Unlocks HDAC Inhibitor Potential
Oncotarget
Oncology
A Novel Tankyrase Inhibitor, MSC2504877, Enhances the Effects of Clinical CDK4/6 Inhibitors
Scientific Reports
Multidisciplinary
HDAC Inhibitor LMK‑235 Promotes the Odontoblast Differentiation of Dental Pulp Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Phase I Study of the mTOR Inhibitor Ridaforolimus and the HDAC Inhibitor Vorinostat in Advanced Renal Cell Carcinoma and Other Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy--Response
Clinical Cancer Research
Cancer Research
Oncology
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2 + Tumors
Cancer Research
Cancer Research
Oncology
Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells
PLoS ONE
Multidisciplinary
